Regeneron pharmaceuticals, inc. (regn) investors who lost money have opportunity to lead securities fraud lawsuit

Los angeles , jan. 23, 2025 /prnewswire/ -- glancy prongay & murray llp announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn). if you suffered a loss on your regeneron investments, click here before march 10, 2025 (lead plaintiff deadline) to participate in the securities fraud lawsuit what is the lawsuit about?
REGN Ratings Summary
REGN Quant Ranking